Latest Ai Technology News

Artrya Limited has expanded its SAPPHIRE clinical study with Ascension, one of the largest US non-profit health systems, joining as the fourth major participant. This move strengthens the study’s reach and advances the evaluation of Artrya’s AI-powered Salix platform for coronary artery disease detection.

Webjet Group’s preliminary 1H26 results reveal resilience in a challenging market, with underlying EBITDA in line with expectations despite a 9% decline. The company revises FY25 figures following an accounting policy change and lowers FY26 EBITDA guidance amid subdued domestic leisure travel and a delayed brand relaunch.

OFX Group reported a 5.6% decline in net operating income for 1H26 amid macroeconomic challenges but showcased strong progress in its OFX 2.0 platform transition and strategic investments aimed at long-term growth.

BrainChip Holdings Ltd has launched a fully underwritten $35 million placement alongside a $2 million share purchase plan to fund the commercialization of its Akida 2.0 technology and new TENNs product development. The capital raise underscores the company’s commitment to expanding its footprint in the rapidly growing edge AI market.

BrainChip Holdings Ltd has secured A$35 million through a fully underwritten placement and an additional A$2 million via a Share Purchase Plan to fast-track its neuromorphic AI technology and product development.

REA Group reported a solid start to FY26 with 4% revenue growth and a key acquisition that enhances its AI-driven property technology portfolio. Despite challenges in India, the Australian market’s strong yield growth and product adoption underpin a confident outlook.

Artrya secures participation from Mass General Brigham, a leading U.S. cardiovascular research center, in its pivotal SAPPHIRE Study launching in early 2026. This collaboration aims to validate Artrya’s AI-powered Salix platform for earlier and more effective coronary artery disease detection.

Strategic Elements Ltd has marked a key milestone by successfully fabricating Energy Ink™ prototype cells in a commercial setting, while expanding its artificial intelligence ventures and maintaining a robust financial position.

PainChek Ltd has achieved a pivotal FDA De Novo clearance for its AI-driven Adult pain assessment app, unlocking the US market and driving its annual recurring revenue to $5.6 million. The company also launched its Infant app, targeting a vast global market of pre-verbal children.

N1 Holdings reports a steady start to FY26 with a $375,000 net profit and robust cash flow, driven by its SME lending operations and enhanced by AI technology.

Loyal Metals Ltd has secured an option to acquire the high-grade Highway Reward Copper-Gold Mine and confirmed significant unmined mineralisation through historic drill data verification, while advancing lithium projects in North America with innovative technology and strong funding.

CurveBeam AI reports a 33% increase in Q1 FY26 purchase orders, secures A$6.5 million in new funding, and finalizes a strategic joint venture for China distribution and manufacturing rights.